Calysta Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Later Stage VC
- Investors
-
17
Calysta General Information
Description
Manufacturer of sustainable industrial products intended to ensure worldwide food security. The company's products offer the shrimp aquaculture industry a new level of transparency by introducing a sustainable protein, which permits users to determine, with a test, the presence of industrial chemicals and transportation fuels, enabling companies to help meet the growing global demand for protein.
Contact Information
Website
www.calysta.comCorporate Office
- 135 West 25th Avenue
- Suite 1027
- San Mateo, CA 94403
- United States
Corporate Office
- 135 West 25th Avenue
- Suite 1027
- San Mateo, CA 94403
- United States
Calysta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series D1) | 09-Sep-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D1) | 26-Jun-2019 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 02-Nov-2018 | Completed | Generating Revenue | |||
| 7. Debt - General | Completed | Generating Revenue | ||||
| 6. Later Stage VC (Series D) | 01-May-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 02-Feb-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 22-Jan-2015 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 11-Dec-2013 | $3M | $8M | Completed | Startup | |
| 2. Grant | 15-Jan-2013 | $3.7M | $5M | Completed | Startup |
Calysta Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A Senior | 21,386,207 | $0.000100 | $0.03 | $0.32 | $0.32 | 1x | $0.32 | 4.96% |
| Series A Junior | 7,681,861 | $0.000100 | $0.03 | $1 | $1 | 1x | $1 | 1.78% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Calysta Comparisons
Industry
Financing
Details
Calysta Competitors (4)
One of Calysta’s 4 competitors is Unibio, a Venture Capital-Backed company based in Roskilde, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Unibio | Venture Capital-Backed | Roskilde, Denmark | ||||
| Arbiom | Venture Capital-Backed | Paris, France | ||||
| Knip (Commercial Products) | Venture Capital-Backed | Boston, MA | ||||
| OmniActive Health Technologies | Private Equity-Backed | Mumbai, India |
Calysta Patents
Calysta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3233940-A1 | Integrated systems and methods for combining methanotrophic bacterial biomass production and methanation process | Pending | 06-Dec-2021 | ||
| EP-4444895-A2 | Integrated systems and methods for combining methanotrophic bacterial biomass production and methanation process | Inactive | 06-Dec-2021 | ||
| US-20230340401-A1 | Integrated systems and methods for combining methanotrophic bacterial biomass production and methanation process | Inactive | 06-Dec-2021 | ||
| WO-2023107901-A2 | Integrated systems and methods for combining methanotrophic bacterial biomass production and methanation process | Inactive | 06-Dec-2021 | ||
| WO-2023107901-A3 | Integrated systems and methods for combining methanotrophic bacterial biomass production and methanation process | Inactive | 06-Dec-2021 | C12N1/30 |
Calysta Signals
Calysta Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ocean 14 Capital | Limited Partner | Minority | ||
| Adisseo | Corporation | Minority | ||
| Western Technology Investment | Venture Capital | Minority | ||
| BP Ventures (London) | Corporate Venture Capital | Minority | ||
| The Engine | Accelerator/Incubator | Minority |
Calysta Investments & Acquisitions (3)
Calysta’s most recent deal was a Joint Venture with Calysseo. The deal was made on 20-Feb-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Calysseo | 20-Feb-2020 | Joint Venture | Other Commercial Products | ||
| NouriTech | 01-Jan-2016 | Corporate | Other Commercial Services | ||
| BioProtein | 20-May-2014 | Merger/Acquisition | Other Commercial Products |
Calysta FAQs
-
When was Calysta founded?
Calysta was founded in 2011.
-
Where is Calysta headquartered?
Calysta is headquartered in San Mateo, CA.
-
What is the size of Calysta?
Calysta has 60 total employees.
-
What industry is Calysta in?
Calysta’s primary industry is Food Products.
-
Is Calysta a private or public company?
Calysta is a Private company.
-
What is Calysta’s current revenue?
The current revenue for Calysta is .
-
How much funding has Calysta raised over time?
Calysta has raised $173M.
-
Who are Calysta’s investors?
Ocean 14 Capital, Adisseo, Western Technology Investment, BP Ventures (London), and The Engine are 5 of 17 investors who have invested in Calysta.
-
Who are Calysta’s competitors?
Unibio, Arbiom, Knip (Commercial Products), and OmniActive Health Technologies are competitors of Calysta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process